Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J. Am. Coll. Cardiol. 76, 2982–3021 (2020).
Article PubMed PubMed Central Google Scholar
Lind, L. et al. Life-time covariation of major cardiovascular diseases. Circ. Genom. Precis. Med. 14, e002963 (2021).
Article CAS PubMed PubMed Central Google Scholar
Sundbøll, J. et al. Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: a nationwide population-based cohort study. Int. J. Cardiol. 241, 182–187 (2017).
Lopes, R. D. et al. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur. Heart J. 30, 2019–2028 (2009).
Article CAS PubMed PubMed Central Google Scholar
Luo, J. et al. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure. ESC Heart Fail. 7, 2762–2772 (2020).
Article PubMed PubMed Central Google Scholar
Lee, J. H. et al. New-onset paroxysmal atrial fibrillation in acute myocardial infarction: increased risk of stroke. BMJ Open 10, e039600 (2020).
Article PubMed PubMed Central Google Scholar
Rathore, S. S. et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 101, 969–974 (2000).
Article CAS PubMed Google Scholar
Fauchier, L. et al. Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis. Clin. Res. Cardiol. 110, 1431–1438 (2021).
Obayashi, Y. et al. Newly diagnosed atrial fibrillation in acute myocardial infarction. J. Am. Heart Assoc. 10, e021417 (2021).
Article PubMed PubMed Central Google Scholar
Harrington, A. W. & Wright, J. H. Cardiac infarction: a study of 148 cases. Glasg. Med. J. 119, 1–12 (1933).
Master, A. M., Dack, S. & Jaffe, H. L. Disturbances of rate and rhythm in acute coronary artery thrombosis. Ann. Intern. Med. 11, 735 (1937).
Simoons, M. L. et al. Improved survival after early thrombolysis in acute myocardial infarction: a randomised trial by the Interuniversity Cardiology Institute in the Netherlands. Lancet 326, 578–581 (1985).
Mintz, S. S. & Katz, L. N. Recent myocardial infarction: an analysis of five hundred and seventy-two cases. Arch. Intern. Med. 80, 205–236 (1947).
Rosenbaum, F. F. & Levine, S. A. Prognostic value of various clinical and electrocardiographic features of acute myocardial infarction: I. Immediate prognosis. Arch. Intern. Med. 68, 913–944 (1941).
Hurwitz, M. & Eliot, R. S. Arrhythmias in acute myocardial infarction. Dis. Chest 45, 616–626 (1964).
Article CAS PubMed Google Scholar
Eldar, M. et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation 97, 965–970 (1998).
Article CAS PubMed Google Scholar
Bengtson, L. G. et al. Temporal trends in the occurrence and outcomes of atrial fibrillation in patients with acute myocardial infarction (from the Atherosclerosis Risk in Communities Surveillance Study). Am. J. Cardiol. 114, 692–697 (2014).
Article PubMed PubMed Central Google Scholar
Grines, C. L. et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N. Engl. J. Med. 328, 673–679 (1993).
Article CAS PubMed Google Scholar
Schömig, A. et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N. Engl. J. Med. 343, 385–391 (2000).
Soliman, E. Z. et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern. Med. 174, 107–114 (2014).
Article PubMed PubMed Central Google Scholar
O’Neal, W. T., Sangal, K., Zhang, Z. M. & Soliman, E. Z. Atrial fibrillation and incident myocardial infarction in the elderly. Clin. Cardiol. 37, 750–755 (2014).
Article PubMed PubMed Central Google Scholar
Chao, T. F. et al. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. Heart Rhythm 11, 1941–1947 (2014).
Soliman, E. Z. et al. Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 131, 1843–1850 (2015).
Article PubMed PubMed Central Google Scholar
Ruddox, V. et al. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis. Eur. J. Prev. Cardiol. 24, 1555–1566 (2017).
Article PubMed PubMed Central Google Scholar
Guo, X. Y. et al. Atrial fibrillation is associated with an increased risk of myocardial infarction: insights from a meta-analysis. Atherosclerosis 254, 1–7 (2016).
Article CAS PubMed Google Scholar
Piccini, J. P. et al. Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. Eur. Heart J. 35, 250–256 (2014).
Yahagi, K., Davis, H. R., Arbustini, E. & Virmani, R. Sex differences in coronary artery disease: pathological observations. Atherosclerosis 239, 260–267 (2015).
Article CAS PubMed Google Scholar
Magnani, J. W. et al. Racial differences in atrial fibrillation-related cardiovascular disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA Cardiol. 1, 433–441 (2016).
Article PubMed PubMed Central Google Scholar
O’Neal, W. T. et al. Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation. PLoS ONE 14, e0222147 (2019).
Article PubMed PubMed Central Google Scholar
Lett, E., Asabor, E., Beltrán, S., Cannon, A. M. & Arah, O. A. Conceptualizing, contextualizing, and operationalizing race in quantitative health sciences research. Ann. Fam. Med. 20, 157–163 (2022).
Article PubMed PubMed Central Google Scholar
Luo, J. et al. Long-term impact of the burden of new-onset atrial fibrillation in patients with acute myocardial infarction: results from the NOAFCAMI-SH registry. Europace 23, 196–204 (2021).
Romanov, A. et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study. Europace 20, 263–270 (2018).
Bloch Thomsen, P. E. et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation 122, 1258–1264 (2010).
Krijthe, B. P. et al. Unrecognized myocardial infarction and risk of atrial fibrillation: the Rotterdam Study. Int. J. Cardiol. 168, 1453–1457 (2013).
Jabre, P. et al. Atrial fibrillation and death after myocardial infarction: a community study. Circulation 123, 2094–2100 (2011).
Article PubMed PubMed Central Google Scholar
Massicotte-Azarniouch, D. et al. Incident atrial fibrillation and the risk of congestive heart failure, myocardial infarction, end-stage kidney disease, and mortality among patients with a decreased estimated GFR. Am. J. Kidney Dis. 71, 191–199 (2018).
Schnabel, R. B. D. et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 386, 154–162 (2015).
Article PubMed PubMed Central Google Scholar
Fang, J., Alderman, M. H., Keenan, N. L. & Ayala, C. Acute myocardial infarction hospitalization in the United States, 1979 to 2005. Am. J. Med. 123, 259–266 (2010).
Staerk, L. et al. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ 361, k1453 (2018).
留言 (0)